Since Karyopharm Therapeutics was founded in 2008, it has participated in 6 rounds of funding. In total Karyopharm Therapeutics has raised $343.3M. Karyopharm Therapeutics' last funding round was on Dec 2022 for a total of $165.0M.
Karyopharm Therapeutics has 8 investors, including Adage Capital Partners LP, Armistice Capital and Healthcor Management LP. The latest investment occurred in Dec 2022.